Central Trust Company’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.43K Sell
49
-29
-37% -$2.46K ﹤0.01% 1329
2026
Q1
$6.52K Buy
78
+15
+24% +$1.23K ﹤0.01% 1224
2025
Q4
$5.77K Buy
63
+6
+11% +$574 ﹤0.01% 1197
2025
Q3
$5.4K Hold
57
﹤0.01% 1184
2025
Q2
$5.97K Hold
57
﹤0.01% 1190
2025
Q1
$5.04K Hold
57
﹤0.01% 1209
2024
Q4
$5.47K Hold
57
﹤0.01% 1191
2024
Q3
$4.67K Hold
57
﹤0.01% 1162
2024
Q2
$4.91K Hold
57
﹤0.01% 1177
2024
Q1
$4.65K Hold
57
﹤0.01% 1178
2023
Q4
$3.78K Hold
57
﹤0.01% 1201
2023
Q3
$4.16K Buy
+57
New +$3.85K ﹤0.01% 1157

Other funds holding HQY

Central Trust Company's HQY Position: Q2 2026 in Review

Central Trust Company reduced its HealthEquity (HQY) stake by 37% in Q2 2026, selling an estimated $2.46K and leaving 49 shares worth $4.43K. The position accounts for ﹤0.01% of the portfolio, ranked #1329.

Central Trust Company first reported a position in HQY in Q3 2023 and has held it in 12 quarters since. The position peaked at $6.52K in Q1 2026. 500 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Central Trust Company held 49 shares of HealthEquity worth $4.43K as of Q2 2026.
  • Central Trust Company sold 29 HealthEquity shares in Q2 2026, an estimated $2.46K.
  • HealthEquity made up ﹤0.01% of Central Trust Company's portfolio in Q2 2026, its #1329 holding.
  • Central Trust Company first reported a position in HealthEquity in Q3 2023 and has held it in 12 quarters since.
  • Central Trust Company's HealthEquity position peaked at $6.52K in Q1 2026.
  • 500 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.